KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Interest Coverage Ratio (2020 - 2025)

Historic Interest Coverage Ratio for Alnylam Pharmaceuticals (ALNY) over the last 6 years, with Q3 2025 value amounting to 8.29.

  • Alnylam Pharmaceuticals' Interest Coverage Ratio rose 47047.93% to 8.29 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.63, marking a year-over-year increase of 21639.03%. This contributed to the annual value of 1.25 for FY2024, which is 4643.31% up from last year.
  • Per Alnylam Pharmaceuticals' latest filing, its Interest Coverage Ratio stood at 8.29 for Q3 2025, which was up 47047.93% from 0.4 recorded in Q2 2025.
  • Alnylam Pharmaceuticals' Interest Coverage Ratio's 5-year high stood at 8.29 during Q3 2025, with a 5-year trough of 7.65 in Q2 2023.
  • Moreover, its 5-year median value for Interest Coverage Ratio was 3.71 (2023), whereas its average is 2.44.
  • As far as peak fluctuations go, Alnylam Pharmaceuticals' Interest Coverage Ratio tumbled by 13231.58% in 2024, and later surged by 47047.93% in 2025.
  • Over the past 5 years, Alnylam Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 5.28 in 2021, then decreased by 19.31% to 6.31 in 2022, then surged by 41.09% to 3.71 in 2023, then rose by 27.35% to 2.7 in 2024, then soared by 407.16% to 8.29 in 2025.
  • Its last three reported values are 8.29 in Q3 2025, 0.4 for Q2 2025, and 0.47 during Q1 2025.